|
MORC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.885500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.405960E-04 |
| Normal-vs-Stage2 |
9.389400E-01 |
| Normal-vs-Stage3 |
1.273360E-01 |
| Normal-vs-Stage4 |
9.393600E-01 |
| Stage1-vs-Stage2 |
2.780200E-01 |
| Stage1-vs-Stage3 |
1.369950E-02 |
| Stage1-vs-Stage4 |
2.036800E-01 |
| Stage2-vs-Stage3 |
2.441000E-01 |
| Stage2-vs-Stage4 |
9.154800E-01 |
| Stage3-vs-Stage4 |
4.039800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.235600E-02 |
| Normal-vs-AfricanAmerican |
1.995200E-01 |
| Normal-vs-Asian |
2.640200E-01 |
| Caucasian-vs-AfricanAmerican |
8.486400E-01 |
| Caucasian-vs-Asian |
1.477230E-01 |
| AfricanAmerican-vs-Asian |
1.357420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0519000004372E-07 |
| Normal-vs-Female |
9.519600E-03 |
| Male-vs-Female |
2.59729999996239E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.702200E-01 |
| Normal-vs-Extreme_Weight |
5.6304000000007E-05 |
| Normal-vs-Obese |
9.186600E-01 |
| Normal-vs-Extreme_Obese |
5.379900E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.008600E-01 |
| Normal_Weight-vs-Obese |
6.497400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.020400E-02 |
| Extreme_Weight-vs-Obese |
5.510100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.298000E-01 |
| Obese-vs-Extreme_Obese |
2.232300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.126780E-01 |
| Normal-vs-Age(41-60Yrs) |
4.982100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.977000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.294100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.334200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.570000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.627900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.217200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.733800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.182000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.88639999865981E-08 |
| Normal-VS-Type2 PRCC |
2.914400E-01 |
| Normal-VS-KIRP CIMP |
2.040500E-03 |
| Normal-VS-Unclassified PRCC |
5.907000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.596100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.965500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.312180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.639410E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.612800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.644980E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.385710E-04 |
| Normal-vs-N1 |
4.636300E-02 |
| Normal-vs-N2 |
7.691200E-01 |
| N0-vs-N1 |
3.516200E-03 |
| N0-vs-N2 |
4.052400E-01 |
| N1-vs-N2 |
5.594200E-01 |
|
|
